These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29345515)

  • 21. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.
    Cho YT; Chen CH; Chiu HY; Tsai TF
    J Dermatol; 2012 Mar; 39(3):269-73. PubMed ID: 22077677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Issues in diagnostic testing and monitoring in HIV/viral hepatitis co-infection.
    Dervisevic S; Pillay D
    J HIV Ther; 2003 Nov; 8(4):89-95. PubMed ID: 14671506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic hepatitis B or C in HIV-infected patients with dual viral hepatitis.
    Soriano V; Barreiro P; Martín-Carbonero L; Castellares C; Ruiz-Sancho A; Labarga P; Ramos B; Gonzalez-Lahoz J
    J Infect Dis; 2007 Apr; 195(8):1181-3. PubMed ID: 17357055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.
    Guido M; Thung SN; Fattovich G; Cusinato R; Leandro G; Cecchetto A; Cesaro S; Panese P; Rugge M
    Mod Pathol; 1999 Jun; 12(6):599-603. PubMed ID: 10392636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection.
    Squadrito G; Orlando ME; Pollicino T; Raffa G; Restuccia T; Cacciola I; Di Marco V; Picciotto A; Colucci G; Craxì A; Raimondo G
    Am J Gastroenterol; 2002 Jun; 97(6):1518-23. PubMed ID: 12094876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: prevalence and clinical significance.
    Cardoso C; Alves AL; Augusto F; Freire R; Quintana C; Gonçalves M; Oliveira AP
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):142-6. PubMed ID: 23044809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased risk of chronic hepatitis in children with cancer.
    Sevinir B; Meral A; Günay U; Ozkan T; Ozuysal S; Sinirtas M
    Med Pediatr Oncol; 2003 Feb; 40(2):104-10. PubMed ID: 12461794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
    Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
    Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
    Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
    Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
    [No Abstract]   [Full Text] [Related]  

  • 32. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis.
    Sagnelli E; Coppola N; Scolastico C; Filippini P; Santantonio T; Stroffolini T; Piccinino F
    Hepatology; 2000 Nov; 32(5):1106-10. PubMed ID: 11050062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An outbreak of fulminant hepatitis B in immunocompromised hemodialysis patients.
    Igaki N; Nakaji M; Moriguchi R; Akiyama H; Tamada F; Oimomi M; Goto T
    J Gastroenterol; 2003; 38(10):968-76. PubMed ID: 14614604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
    Maier KP
    Praxis (Bern 1994); 2003 Aug; 92(33):1351-7. PubMed ID: 14502791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
    Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
    Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
    Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
    Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
    Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study.
    Qin H; Liu N; Hu Y; Yu N; Yi X; Gao Y; Chen F; Gu J; Ding Y; Shi Y
    Eur J Dermatol; 2022 May; 32(3):394-400. PubMed ID: 36065536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
    Chu CM; Sheen IS; Liaw YF
    Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.
    Piaserico S; Dapavo P; Conti A; Gisondi P; Russo FP
    J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1853-1859. PubMed ID: 28146345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.